Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

291 - 300 of 57753 results found

COVID-19 Vaccines: Where Did We Stand at the End of 2023?

Date
Saturday, February 24, 2024 - 4:00 AM
Description
Vaccine development against SARS-CoV-2 has been highly successful in slowing down the COVID-19 pandemic. A wide spectrum of approaches including vaccines based on whole viruses, protein subunits and peptides, viral vectors, and nucleic acids has been

S-Gene Target Failure as an Effective Tool for Tracking the Emergence of Dominant SARS-CoV-2 Variants in Switzerland and Liechtenstein, Including Alpha, Delta, and Omicron BA.1, BA.2, and BA.4/BA.5

Date
Saturday, February 24, 2024 - 4:00 AM
Description
During the SARS-CoV-2 pandemic, the Dr. Risch medical group employed the multiplex TaqPath^(TM) COVID-19 CE-IVD RT-PCR Kit for large-scale routine diagnostic testing in Switzerland and the principality of Liechtenstein. The TaqPath Kit is a widely

COVID-19 and influenza vaccine co-administration among older U.S. adults

Date
Saturday, February 24, 2024 - 4:00 AM
Description
CONCLUSIONS: Among Medicare beneficiaries vaccinated against COVID-19, influenza vaccination was high, but co-administration of the two vaccines was low. Future work should explore which factors explain variation in the decision to receive co